12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Telesis Bio (TBIO) led the gainers with a 32.5% increase, while Impel Pharmaceuticals (IMPL) saw the largest decline among the losers, dropping 13.3%. Other notable movers included Femasys (FEMY), Axcella Health (AXLA), and Gyre Therapeutics (GYRE), which released its Q1 earnings report.
November 22, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Gyre Therapeutics stock fell 8.67% to $14.97 following its Q1 earnings report, with a market cap of $1.1 billion.
The decline in Gyre Therapeutics' stock price post-earnings suggests a negative market response to the report, which could continue in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Impel Pharmaceuticals stock declined by 13.3% to $0.68, with a market cap of $16.1 million.
The significant drop in Impel Pharmaceuticals' stock price could indicate a bearish trend that may persist in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Axcella Health shares rose 13.1% to $5.18, with a market cap of $15.2 million.
Axcella Health's after-market increase could signal a bullish short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Femasys shares increased by 19.28% to $1.09, with a market cap of $23.5 million.
The rise in Femasys shares indicates a positive reaction from the market, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Telesis Bio shares soared 32.5% in after-market trading, with a market cap of $15.8 million.
The significant after-market gain for Telesis Bio suggests positive investor sentiment which could lead to a short-term uptrend in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100